Amgen stock at EUR 417.20, up 0.81% before Xetra
Published on 11/09/2026 at 08:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat matters before the open
- Amgen stock is indicated above the last Xetra close ahead of Monday's European session.
- Amgen's investor-relations releases span cardiovascular, oncology and rare-disease medicines.
Amgen stock traded at EUR 417.20 on Lang & Schwarz at 08:29 CET on Monday, November 9, 2026, 0.81% above the Xetra close of Friday, November 6, 2026 at EUR 413.85.
The indication puts the stock above its most recent Xetra session as investors prepare for the European market open. The move clears the 0.50% threshold used for this premarket report, while the underlying reference remains Friday's closing level.
Pipeline breadth remains in focus
Amgen's investor-relations releases cover medicines and clinical developments across cardiovascular care, oncology and rare diseases. That breadth leaves product execution and upcoming clinical updates as important themes for investors alongside the company's financial outlook.
Investors can follow the real-time quote of Amgen stock during the session.
The S&P 500 will provide the broader US market backdrop for Amgen's US-listed shares.
More company-specific developments are available in More news and analyses on Amgen stock.
